Clinical trial
Evaluating the Impact of SomaSignal Tests on Medical Management and Change in Risk in Patients With Type 2 Diabetes at Higher Risk of Cardiovascular Disease
NCT05256706 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Impact of SomaSignal Tests on Medical Management and Change in Risk in Patients With Type 2 Diabetes at Higher Risk of Cardiovascular Disease
- Lead sponsor
- Emory University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 3, 2022
- Completion date
- December 9, 2023
- Enrollment
- 143 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.